TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Tillotts Pharma AB
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
403,003
|
460,633
|
323,970 |
Financial expenses |
4,569
|
198
|
1,823 |
Earnings before taxes |
4,308
|
11,577
|
5,343 |
EBITDA |
7,130
|
11,678
|
5,226 |
Total assets |
190,219
|
161,095
|
214,909 |
Current assets |
189,966
|
160,847
|
214,293 |
Current liabilities |
130,799
|
104,738
|
167,518 |
Equity capital |
45,420
|
42,357
|
33,391 |
- share capital |
100
![]() |
100
![]() |
100 |
Employees (average) |
21
|
19
|
18 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
23.9%
|
26.3%
|
15.5% |
Turnover per employee |
19,191
|
24,244
|
17,998 |
Profit as a percentage of turnover |
1.1%
|
2.5%
|
1.6% |
Return on assets (ROA) |
4.7%
|
7.3%
|
3.3% |
Current ratio |
145.2%
|
153.6%
|
127.9% |
Return on equity (ROE) |
9.5%
|
27.3%
|
16.0% |
Change turnover |
-57,630
|
136,663
|
4,683 |
Change turnover % |
-13%
|
42%
|
1% |
Chg. No. of employees |
2
|
1
|
2 |
Chg. No. of employees % |
11%
|
6%
|
13% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.